Navigation Links
New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
Date:5/20/2008

WILMINGTON, Del., May 20 /PRNewswire-FirstCall/ -- A new open-label study evaluated patient satisfaction with budesonide/formoterol combination therapy and fluticasone/salmeterol combination therapy, as measured by the Asthma Treatment Satisfaction Measure (ATSM)(1). Patients participating in the study were ages 18 years and older with moderate to severe asthma(1) and had been previously treated with inhaled corticosteroids(1). Results were presented today at the International Conference of the American Thoracic Society held in Toronto, May 16-21, 2008.

Results showed that patients receiving budesonide/formoterol combination therapy administered as adjustable dosage reported significantly greater satisfaction on the ATSM overall (p=0.02) than patients receiving fluticasone/salmeterol combination therapy, especially in the categories of feel medication begins to work (p<0.001), dosing management (p<0.001), and timely relief of symptoms (p=0.037)(1). Patients receiving budesonide/formoterol combination therapy fixed dose reported significantly greater satisfaction for timely relief of symptoms (p=0.002) and feeling the medication begin to work (p=0.02) compared to patients receiving fluticasone/salmeterol combination therapy(1). Budesonide/formoterol combination therapy is not indicated for adjustable dosing in the U.S.

"These data showed that patients treated with budesonide/formoterol combination therapy fixed dose were more satisfied with the timeliness of their symptom relief than those patients treated with fluticasone/salmeterol combination therapy," said lead investigator Richard O'Connor, MD, of the University of California-San Diego.

About the ATSM

Patient satisfaction was assessed using the recently validated 11-item Asthma Treatment Satisfaction Measure (ATSM)(1). Scores range from 0-100, with the higher scores equaling greater satisfaction(1). Categories included symptom relief, onset of action, sensations that medication
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
2. Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease
3. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
4. Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
5. Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy
6. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
7. Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008
8. CBI and PharmaVoice Announce Recipients of the Strategic Patient Adherence Awards
9. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
10. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
11. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... SAN DIEGO , Feb. 9 ... that Felix J. Baker , Ph.D., has been ... is a managing partner of Baker Bros. Advisors, LLC, ... Brothers Investments, Ardea,s largest shareholder. ,, "Ardea,s impressive ... portfolio, so I am pleased to join the Board ...
(Date:2/9/2010)... California and AMSTERDAM , February ... molecular cancer diagnostics, announced today that,it has received ... York State ,Department of Health. The New ... receive,commercial samples of MammaPrint, its FDA-cleared breast cancer ... latest permit, Agendia has now obtained all major ...
(Date:2/8/2010)... , Feb. 8 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., ... traditional Chinese medicine ("TCM") based in Chengdu, China ... December 31, 2009 . , , ... Million, Net Income Increased, ... $0.11 on a diluted basis, -- ...
(Date:2/8/2010)... , Feb. 8 Biocell ... with maternal-fetal-medicine doctors by attending the Society for ... has been working with perinatologists and Ob/Gyn doctors ... , CEO of Biocell Center Corporation. "We understand ... mothers and families and we are hoping to ...
Breaking Biology Technology:Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors 2Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors 3Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists 2Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 2Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 3Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 4Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 5Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 6Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 7Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 8Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 9Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 10Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 11Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 12Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 13Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 14Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 15Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 16Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 17Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine 2
... WYE ) today,announced that Michael Kamarck, ... & Product Supply (TO&PS). Dr. Kamarck will ... product supply for,Wyeth, including its Pharmaceutical, BioPharma, Vaccine, ... Portwood, 58, who has been,appointed to the new ...
... Neurocrine Biosciences, Inc.,(Nasdaq: NBIX ) announced today ... Biosciences will be presenting at the 20th,Annual Piper Jaffray ... The live "fireside chat" presentation ... Time (ET) /10:30 a.m. Pacific Time (PT). The,presentation will ...
... MINRAD International, Inc. (Amex: BUF ), announced effective ... 50 positions. , , ... taken this difficult, but necessary action to reduce our cost ... adverse financial condition as we discussed in our recently announced ...
Other Biology Technology:Wyeth Names Michael Kamarck President, Technical Operations & Product Supply 2MINRAD International, Inc. Announces Reduction in Workforce 2
(Date:2/9/2010)... HUNTSVILLE, TX- The United States Army has taken delivery ... treatment system that will clean putrid water within 24 ... at Sam Houston State University. , "The system is ... find them in a common handful of dirt," said ... and in the right medium, they have the ...
(Date:2/9/2010)... majority owned subsidiary of Avisio, Inc. acquired an ... , The technology is based on an ... e.g. mosquitos and black flies, utilize their olfactory ... animals and humans. CO2, which is a major ... insect to its prey. , Developed by ...
(Date:2/9/2010)... FOOTHILL RANCH, Calif. , Feb. 9 ... , a leading supplier of innovative computer products ... solutions, today announced that the luxurious new ... British Columbia , Canada is using the new ... to more accurately manage its inventory of 10,000 ...
Breaking Biology News(10 mins):'Revolutionary' water treatment units on their way to Afghanistan 2'Revolutionary' water treatment units on their way to Afghanistan 3New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 2New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 3New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 4New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 5Compirion Healthcare Sponsors Free Webinar On Achieving Early Hospital Discharges 51368 1Compirion Healthcare Sponsors Free Webinar On Achieving Early Hospital Discharges 51368 2Compirion Healthcare Sponsors Free Webinar On Achieving Early Hospital Discharges 51368 3Milwaukee VA Hospital Gains New Spinal Cord Treatment Center 51366 1Pioneer Surgical Technology Inc Names Thomas J McLeer as Chief Marketing Officer and General Manager of Spinal Operations 51364 1Pioneer Surgical Technology Inc Names Thomas J McLeer as Chief Marketing Officer and General Manager of Spinal Operations 51364 2
... has been awarded to the Intergov-ernmental Panel on Climate Change ... knowledge about man-made climate change, and to lay the foundations ... In particular, the 4th United Nations Climate Report on ... February and May 2007 revealed new facts and has been ...
... permits are all the rage in environmental policy. They ... improve air quality. A group of economists and ecologists ... together to find out whether such schemes could work ... probably only for cultural landscapes like farmland. , The ...
... a hidden weapon that one of the most invasive ... and efficiently bump off its neighbors. , The invasive ... have originated in Eurasia, exudes from its roots an ... structural protein in the roots of neighboring plants, thus ...
Other Biology News:Nobel Peace Prize 2007 to intergovernmental panel on climate change 2Buying and selling habitats to help wildlife 2UD plant biologists uncover top wetland plant's hidden weapon 2UD plant biologists uncover top wetland plant's hidden weapon 3
acridine orange 10-nonyl bromide (nonyl acridine orange)...
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure grade propidium iodide is greater than or equal to 98% pure by HPLC....
MOUSE ANTI RAT RT1Bu Immunogen: Rat thymocyte membrane glycoproteins...
... of BAC (100+kb), fosmid (40kb), and large ... than any othe BAC vector. On command ... and easy recombinant DNA purification. Available with ... VC) vectors for the highest insert stability. ...
Biology Products: